Home
Paladin Pharma

Paladin Pharma Market Share Analysis for June 2026

Industry: N/A

Domainpaladin-pharma.com

Year Founded1996

Employees51 - 200

Annual Revenue--

Paladin Pharma

Paladin Pharma (including company regionals)

paladin-pharma.com

See more website traffic and engagement information

Total visits to Paladin Pharma's top domains

Understand Paladin Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

paladin-pharma.com490

See more with Sales Intelligence

Avg. visit duration in Paladin Pharma's top domains

Analyze Paladin Pharma engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Paladin Pharma's top domains

See how Paladin Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

paladin-pharma.com1.10

See more with Sales Intelligence

Paladin Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Paladin Pharma

These are the website technologies, by industry, used by Paladin Pharma top domains

Widget (3)

Twemoji

Content Management System (2)

WordPress

Conversion & Analytics (1)

Google Analytics

Marketing (1)

Google Marketing Platform

More Technologies

2

See all

News & Signals from Paladin Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPaladin Pharma Inc. partnered with MC2 Therapeutics, Ltd. on Nov 1st '24.In November 2024, Paladin had entered into a license agreement with MC2 Therapeutics ("MC2") to commercialize WYNZORA(R) in Canada.

NewsMyRx Care Inc. partners with Paladin Pharma Inc..MyRx Care, a leading provider of patient financial assistance solutions, is pleased to announce a new partnership with Paladin Pharma, a pharmaceutical company committed to improving the lives of patients across Canada.

NewsKnight Therapeutics Inc. acquired Paladin Pharma Inc. for $99M on Mar 22nd '25.In a move set to reshape the Canadian pharmaceutical landscape, Knight Therapeutics Inc. has agreed to acquire Paladin Pharma from Endo Inc. for up to $99 million.